Pharmacogenetics Committee
Chair: R. Van Schaik (r.vanschaik@erasmusmc.nl)
Vice chair: Vincent Haufroid (vincent.haufroid@uclouvain.be)
Background/Purpose of the Committee
• To promote the knowledge, understanding and implementation of pharmacogenetics among scientists, laboratory and clinicians.
Committee Membership List
Chair: Dr. Ron van Schaik, Clinical Chemist – Erasmus University Medical Hospital
Vice-chair: Dr. Vincent Haufroid, Cliniques universitaires Saint-Luc – UCL, Laboratory of Analytical Biochemistry & Louvain center for Toxicology and Applied Pharmacology (LTAP), Bruxelles.
Members: R. Van Schaik, V. Haufroid, T. Van Gelder, M. Linder, W. Steimer, I. McPhee, P. Marquet.
Members who would like to get actively involved in one of these projects or other members who would like to propose new projects are very welcome!
Minutes of the Pharmacogenetics Committee Meeting at the Montreal IATDMCT Congress (on October 5, 2009):
During the meeting the purpose of the committee as well as initiatives for the next two years were discussed. It was agreed that for the time being, the committee will limit itself on giving input for the Biannual IATDMCT Meeting in Stuttgart. Ron mentioned that the IFCC has started a Task Force Pharmacogenetics, for which he is the chair. Collaborations between IATDMCT and IFCC would be beneficial. There has been a meeting and presentations of PGx Committee members (Ron van Schaik, Werner Steimer, Iain McPhee) at the IFCC Worldlab Meeting 2008 in Fortaleza, Brazil. This has been communicated and published in the IATDMCT Compass. In addition, a contribution of IATDMCT at the 2009 IFCC EuroMedLa b meeting in Innsbruck, Austria. Ron van Schaik and Pierre Marquet both gave two presentations there. In May 2009, members of the IATDMCT PGx committee participated in the Biomarker Working Group/ISD Committee meeting in Barcelona to discuss implementation of pharmacogenetics.
Committee initiatives for 2010/2011.
• Providing input for the pharmacogenetics program for Stuttgart.
Biomarkers Working Group (BWG)/ISD and PGx Committee meeting.
Report from a Round Table Meeting held in Barcelona last March
